Drug Shortage Report for METHOXISAL-C 1/4
Report ID | 8041 |
Drug Identification Number | 01966367 |
Brand name | METHOXISAL-C 1/4 |
Common or Proper name | METHOXISAL |
Company Name | TEVA CANADA LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ACETYLSALICYLIC ACID METHOCARBAMOL CODEINE PHOSPHATE |
Strength(s) | 325MG 400MG 16.2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 24 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2013-12-01 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2017-10-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-04-25 | French | Compare |
v1 | 2017-04-25 | English | Compare |
Showing 1 to 2 of 2